Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Oral Maxillofac Surg ; 74(1): 53.e1-7, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26433040

RESUMEN

PURPOSE: The effect of a single-dose of pre-emptive pregabalin is still unknown, although it is used as an adjuvant in controlling acute postoperative pain. The purpose of this study was to evaluate the effects of pre-emptive single-dose pregabalin on postoperative acute pain and 24-hour opioid consumption in patients who underwent double-jaw surgery. PATIENTS AND METHODS: Forty patients (18 to 45 yr old; American Society of Anesthesiologists status I to II) for whom elective double-jaw surgery was planned under general anesthesia were included in this study, which had been planned as a prospective, randomized, and double-blinded study. Patients were randomly divided into 2 groups: the pregabalin group (n = 20) was given pregabalin 150 mg orally 1 hour before general anesthesia and the placebo group (n = 20) was given an oral placebo capsule. The groups were administered the routine general anesthesia protocol. Postoperative analgesia was performed intravenously in the 2 groups twice a day with dexketoprofen trometamol 50 mg and patient-controlled analgesia with fentanyl. Postoperative analgesia was evaluated using the visual analog scale (VAS). Fentanyl consumption, additional analgesia requirement, and side-effects were recorded during the first 24 hours after surgery. Descriptive and bivariate statistics were computed, and significance was set at a P value less than .05. RESULTS: Compared with placebo, the VAS score was statistically lower in the pregabalin group during the early postoperative period (P < .05). The 24-hour opioid consumption was significantly higher in the placebo group compared with the pregabalin group (509.40 ± 261.56 vs. 260.10 ± 246.53 µq, respectively; P = .004). In addition, the analgesia requirement was statistically lower in the pregabalin group (P < .05). Nausea or vomiting was observed more often in the placebo group, whereas other side-effects were similar for the 2 groups. CONCLUSION: A single 150-mg dose of pre-emptive pregabalin decreased postoperative opioid consumption in the first 24 hours after double-jaw surgery. Multimodal analgesia techniques that contain pre-emptive analgesia can be used successfully in preventing postoperative pain caused by orthognathic surgery.


Asunto(s)
Analgésicos/uso terapéutico , Narcóticos/uso terapéutico , Procedimientos Quirúrgicos Ortognáticos/métodos , Dolor Postoperatorio/prevención & control , Pregabalina/uso terapéutico , Premedicación , Adolescente , Adulto , Analgesia Controlada por el Paciente/métodos , Analgésicos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Método Doble Ciego , Femenino , Fentanilo/administración & dosificación , Fentanilo/uso terapéutico , Estudios de Seguimiento , Humanos , Cetoprofeno/análogos & derivados , Cetoprofeno/uso terapéutico , Masculino , Persona de Mediana Edad , Narcóticos/administración & dosificación , Osteotomía Le Fort/métodos , Osteotomía Sagital de Rama Mandibular/métodos , Dimensión del Dolor/métodos , Placebos , Náusea y Vómito Posoperatorios/etiología , Pregabalina/administración & dosificación , Estudios Prospectivos , Trometamina/uso terapéutico , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA